Emil A Tanghetti Selected Research

tazarotene (Tazorac)

8/2021	Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits.
8/2021	Fixed-Combination Halobetasol Propionate/Tazarotene Lotion for Psoriasis in Patients With 3%-5% Affected Body Surface Area.
6/2021	Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology.
1/2021	Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex.
6/2020	New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis.
1/2020	Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis.
8/2018	Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.
2/2005	A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
10/2004	Topical tazarotene in acne vulgaris: treatment approaches.
2/2002	Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emil A Tanghetti Research Topics

Disease

13	Acne Vulgaris 01/2022 - 02/2002
6	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2021 - 08/2009
6	Rosacea (Acne Rosacea) 01/2021 - 01/2015
6	Erythema 01/2021 - 01/2015
4	Cicatrix (Scar) 12/2017 - 07/2003
1	Pain (Aches) 01/2020
1	Disease Progression 06/2018
1	Actinic Keratosis 11/2015
1	Inflammation (Inflammations) 09/2013
1	Telangiectasis (Telangiectasia) 02/2012
1	AIDS-Related Complex (ARC) 02/2011
1	Lentigo (Lentiginosis) 02/2005
1	Hyperpigmentation 02/2005
1	Vitiligo 02/2003

Drug/Important Bio-Agent (IBA)

11	tazarotene (Tazorac)FDA Link 08/2021 - 02/2002
5	halobetasol (ulobetasol)FDA LinkGeneric 08/2021 - 08/2018
4	Oxymetazoline FDA Link 01/2021 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2009
3	Benzoyl Peroxide FDA LinkGeneric 01/2022 - 02/2002
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 08/2009
2	RetinoidsIBA 01/2022 - 01/2009
2	clindamycin phosphate (Clindets)FDA LinkGeneric 01/2022 - 02/2002
2	MucinsIBA 11/2016 - 01/2016
2	CollagenIBA 11/2016 - 01/2016
1	Drug CombinationsIBA 01/2022
1	Adapalene (Differin)FDA LinkGeneric 01/2022
1	GelsIBA 01/2022
1	Therapeutic UsesIBA 08/2021
1	EmulsionsIBA 01/2020
1	Dapsone FDA Link 06/2018
1	gallium arsenide (GaAs)IBA 06/2018
1	Fluorouracil (Carac)FDA LinkGeneric 11/2015
1	Aminolevulinic Acid (Levulan)FDA Link 11/2015
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2015
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2015
1	Peptide Hydrolases (Proteases)FDA Link 09/2013
1	LipidsIBA 09/2013
1	NeuropeptidesIBA 09/2013
1	CytokinesIBA 09/2013
1	DefensinsIBA 09/2013
1	calcipotriene (calcipotriol)FDA LinkGeneric 08/2009
1	Vitamin D FDA LinkGeneric 08/2009
1	Pharmaceutical PreparationsIBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 07/2003
1	Immunologic Factors (Immunomodulators)IBA 02/2003
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2003
1	Ointments (Pastes)IBA 02/2003
1	Erythromycin (Erycette)FDA LinkGeneric 02/2002
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2002

Therapy/Procedure

7	Therapeutics 08/2021 - 02/2002
3	Dye Lasers 02/2012 - 07/2003
1	Lasers (Laser) 12/2017
1	Rejuvenation 12/2017
1	Tattooing 12/2017
1	Skin Care 06/2017
1	Baths 06/2017
1	Aftercare (After-Treatment) 11/2016
1	Solid-State Lasers 01/2016
1	Photochemotherapy (Photodynamic Therapy) 11/2015